Cervel Neurotech
Cervel Neurotech raises $11M for device-based depression therapy
California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders.
Funding: Cervel Neurotech raises $14.1M for drug-free brain-stimulation depression therapy
Privately held Cervel Neurotech raised $14.1 million in support of its technology-based therapy for depression, pain and other conditions, according to a company announcement.